Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Grade C

No BS RX review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

NoBsRx publishes standard program figures of $179 for injectable semaglutide and $249 for injectable tirzepatide, but its fee disclosures leave the complete delivered total unconfirmed. Obtain one itemized quote before comparing it with an all-inclusive plan.

Consult Medication
See plans at No BS RX
  • Confirm HSA / FSA coverage
  • Public information reviewed
  • Confirm your total cost
Compare alternatives ↓

No BS RX at a glance

Semaglutide
Program from $179/mo; complete total unconfirmed
Tirzepatide
Program from $249/mo; complete total unconfirmed
Coverage
No list published; it says it is not in all of them
Brand-name
Compounded only

How we scored No BS RX

Every factor comes from No BS RX's own published pricing, disclosures and oversight, and the six combine into the 40/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

Postpartum & breastfeeding guidance18/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit18/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Clinical oversight & labs50/100 · Weak

Oversight and lab support fall short of the best on our list — the review below says exactly where.

True monthly cost68/100 · Weak

Cost is unpredictable or sits at the premium end.

Ongoing support54/100 · Weak

Support is thin once the prescription ships.

Cancellation fairness42/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we checked this review

$179 and $249 month to month, with a genuinely cheap $140 low-dose way in. But its FAQ says there are no platform fees while its disclosures say pharmacy and shipping charges are separate from them, no company is named anywhere, and nothing addresses nursing or PCOS.

Pricing

MedicationPricePlan
Compounded semaglutide$179Standard injection, month to monthIts most-chosen plan. By block: $499 for 12 weeks, $999 for 24, $1,899 for 52. Complete medication, pharmacy, dispensing, shipping and platform charges require an itemized quote; conflicting no-extra-fee FAQ does not establish all-in total.
Compounded semaglutide$140Injectable microdose, month to monthIts low-dose program, filed on its own pricing page under "Microdosing". $409 if you prepay twelve weeks. Complete medication, pharmacy, dispensing, shipping and platform charges require an itemized quote; conflicting no-extra-fee FAQ does not establish all-in total.
Oral semaglutide$199Standard oral tablet, month to month$579 for 12 weeks, $1,149 for 24, $2,199 for 52. The oral microdose is $179 a month. Complete medication, pharmacy, dispensing, shipping and platform charges require an itemized quote; conflicting no-extra-fee FAQ does not establish all-in total.
Compounded tirzepatide$249Standard injection, month to month$649 for 12 weeks, $1,289 for 24, $2,599 for 52. Complete medication, pharmacy, dispensing, shipping and platform charges require an itemized quote; conflicting no-extra-fee FAQ does not establish all-in total.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what No BS RX's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

What we like

  • The full price table is published before any intake
  • Lists a separate lower-dose program from $140; clinical suitability and complete charges require confirmation.
  • No price changes as the dose climbs, said outright
  • Says compounding is done at state-licensed 503A pharmacies
  • Admits it is neither a pharmacy nor a medical practice rather than implying otherwise

The caveats

  • Its "no platform fees" claim contradicts its own disclosures page
  • Pharmacy, dispensing and shipping charges are payable separately, per its own fine print
  • Platform fees are non-refundable once a clinical review has started
  • Names no operating company in its terms, privacy policy, disclosures or footer
  • Publishes no state list and concedes it is not available everywhere
  • Nothing about nursing, postpartum timing or PCOS

The visible program rates are not a settled delivered total

NoBsRx publishes standard injectable semaglutide at $179 monthly and tirzepatide at $249, with oral semaglutide at $199. It also lists lower-dose programs separately. Those figures are useful to identify a proposed program, but the company's financial disclosures describe pharmacy, dispensing and shipping charges as additional to platform fees. A prospective patient therefore needs the complete clinical and pharmacy bill rather than treat the public program amount as an established all-in medication-and-care total.

That qualification conflicts with the FAQ's statement that there are no platform fees layered on top and that the displayed price is what the patient pays. The useful response is a written breakdown, not silently choosing whichever statement is more favorable. Ask which charge buys platform access, which buys medical review, what the actual medicine and delivery cost and whether the components recur together. A price-flat claim across doses can simplify one part of the bill while leaving the total unresolved when separate parties collect required charges.

Standard, oral and lower-dose offers remain distinct

The price table lists longer standard injection terms and an oral route with their own amounts, while a lower-dose injection starts at $140. That smaller figure should not be treated as the standard semaglutide or tirzepatide rate or described as automatically gentler or safer. The clinician should explain the actual medication, formulation, quantity and rationale before a patient chooses on price. A compounded oral preparation also should not inherit an approved tablet's labeling or research because a familiar ingredient name appears in the description.

For longer options, the table uses twelve-, twenty-four- and fifty-two-week terms. Those durations should stay visible rather than be casually renamed three, six and twelve calendar months. Ask for the full payment, supply and renewal schedule associated with the selected term. A weekly duration or monthly equivalent does not establish installment rights, a refund for unused supply or what happens after a prescription change. The financial agreement needs to address interruption rather than leave the patient to calculate it from a list of package amounts.

Platform, clinician and pharmacy each have a role

NoBsRx says it is not a pharmacy or medical practice and does not determine clinical eligibility. It describes state-licensed 503A pharmacy fulfillment without naming an actual dispenser in the available material. No operating company is clearly identified in the Terms, privacy notice or footer. Before sharing a detailed history or paying, request the legal seller, treating practice, clinician and pharmacy names. A telephone number and access-platform description do not establish the whole care chain or who handles a particular medication or billing concern.

The service admits it is not available in every state but does not publish the list. Confirm the selected treatment and location directly. Platform fees become nonrefundable once clinical review begins, while other provider and pharmacy charges have their own conditions. Obtain those rules before choosing a plan. Public information also does not establish a dedicated maternal or PCOS pathway. NoBsRx is most useful to assess after its straightforward-looking table becomes a complete delivered quote, with the fee contradiction, actual week terms and separate professional responsibilities resolved rather than masked by a lower-dose headline.

The bottom line for mothers

Best for: Someone who wants a cheap low-dose way in and will insist on an itemized written total, pharmacy charges included, before paying.

Alternatives to No BS RX

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • EverPrime is a separate consumer brand operated by Enhance MD, LLC. Its live one-month selectors display $249 for compounded semaglutide and $329 for tirzepatide without membership. Core member medication prices exclude a separately billed $99 membership. Delivery is every four weeks, while prices are labeled per month and membership can be prepaid. Confirm the full upfront charge, renewal dates, state eligibility and care fees before choosing a plan.

    Visit EverPrime
  • Current public pages do not establish the full semaglutide and tirzepatide plan prices. Earlier recorded prices retain their original verification date; confirm the complete quote and renewal terms before sharing intake details.

    Visit HumeCare+

Providers like No BS RX

Keep comparing No BS RX

No BS RX, answered

Is the table price everything I'd pay?
It depends which page you read, and that is the uncomfortable part. The FAQ says there are no platform fees on top of the program price. The Disclosures page says pharmacy, dispensing and shipping charges are payable to the pharmacy and separate from platform fees. Ask for a written, itemized total before you enter a card.
Does NoBsRx offer a lower-dose program?
A separate lower-dose injectable program is listed from $140, with a twelve-week option at $409. The clinician must assess suitability; the lower dose is not evidence of greater safety, improved tolerability or equivalent outcomes, and complete additional charges still need clarification.
Which company is behind it?
None is named. The terms, the privacy policy, the disclosures and the footer contain no LLC, corporation or trading name at all — only a phone number and an email address. For a prescription medication, knowing which legal entity is taking your money is not a lot to ask.
Does it cover breastfeeding or PCOS?
The public material does not establish a dedicated breastfeeding, postpartum or PCOS pathway. Discuss the relevant history and care needs directly with the actual treating clinician.

Pricing, states and verification reflect No BS RX's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers